Mattsson, N., Zegers, I., Andreasson, U., Bjerke, M., Blankenstein, M. A., Bowser, R., Carrillo, M. C., Gobom, J., Heath, T., Jenkins, R., Jeromin, A., Kaplow, J., Kidd, D., Laterza, O. F., Lockhart, A., Lunn, M. P., Martone, R. L., Mills, K., Pannee, J., Ratcliffe, M., Shaw, L. M., Simon, A. J., Soares, H., Teunissen, C. E., Verbeek, M. M., Umek, R. M., Vanderstichele, H., Zetterberg, H., Blennow, K., & Portelius, E. (2012). reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. Biomarkers in medicine, 6, 409–417. http://access.bl.uk/ark:/81055/vdc_100130589001.0x000030